Terms: = Ovarian cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
16 results:
1. Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.
Xu AM; Haro M; Walts AE; Hu Y; John J; Karlan BY; Merchant A; Orsulic S
Sci Adv; 2024 Apr; 10(16):eadk8805. PubMed ID: 38630822
[TBL] [Abstract] [Full Text] [Related]
2. Tumor and local lymphoid tissue interaction determines prognosis in high-grade serous ovarian cancer.
Lu H; Lou H; Wengert G; Paudel R; Patel N; Desai S; Crum B; Linton-Reid K; Chen M; Li D; Ip J; Mauri F; Pinato DJ; Rockall A; Copley SJ; Ghaem-Maghami S; Aboagye EO
Cell Rep Med; 2023 Jul; 4(7):101092. PubMed ID: 37348499
[TBL] [Abstract] [Full Text] [Related]
3. Tertiary Lymphoid Structures Are Associated with a Favorable prognosis in High-Grade Serous ovarian cancer Patients.
Zhang K; Xie X; Zou LH; Guo SQ
Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
[TBL] [Abstract] [Full Text] [Related]
4. circANKRD17(has_circ_0007883) confers paclitaxel resistance of ovarian cancer via interacting with fus to stabilize FOXR2.
Liang YX; Zhang LL; Yang L
Mol Cell Biochem; 2023 Apr; 478(4):835-850. PubMed ID: 36107285
[TBL] [Abstract] [Full Text] [Related]
5. CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M; Hamanishi J; Yoshitomi H; Yamanoi K; Takamatsu S; Ueda A; Suzuki H; Hosoe Y; Furutake Y; Taki M; Abiko K; Yamaguchi K; Nakai H; Baba T; Matsumura N; Yoshizawa A; Ueno H; Mandai M
JCI Insight; 2022 Jun; 7(12):. PubMed ID: 35552285
[TBL] [Abstract] [Full Text] [Related]
6. Type II enteropathy-associated T cell lymphoma in the duodenum: A rare case report.
Liu Z; He L; Jiao Y; Wang H; Suo J
Medicine (Baltimore); 2020 Jun; 99(23):e20050. PubMed ID: 32501967
[TBL] [Abstract] [Full Text] [Related]
7. Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.
Heijs B; Holst-Bernal S; de Graaff MA; Briaire-de Bruijn IH; Rodriguez-Girondo M; van de Sande MAJ; Wuhrer M; McDonnell LA; Bovée JVMG
Lab Invest; 2020 Sep; 100(9):1252-1261. PubMed ID: 32341520
[TBL] [Abstract] [Full Text] [Related]
8. A Transcriptionally Distinct CXCL13
Workel HH; Lubbers JM; Arnold R; Prins TM; van der Vlies P; de Lange K; Bosse T; van Gool IC; Eggink FA; Wouters MCA; Komdeur FL; van der Slikke EC; Creutzberg CL; Kol A; Plat A; Glaire M; Church DN; Nijman HW; de Bruyn M
Cancer Immunol Res; 2019 May; 7(5):784-796. PubMed ID: 30872264
[TBL] [Abstract] [Full Text] [Related]
9. Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.
Ishii Y; Fujisawa S; Ando T; Suzuki T; Ishiyama Y; Kishimoto K; Hattori Y; Nakajima Y; Miyazaki T; Takasaki H; Matsumoto K; Koharazawa H; Taguchi J; Fujimaki K; Sakai R; Nakajima H
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e455-e459. PubMed ID: 29984481
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior prognosis in ovarian cancer.
Kroeger DR; Milne K; Nelson BH
Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251
[TBL] [Abstract] [Full Text] [Related]
11. Primary ovarian malignant lymphoma presenting as ovarian carcinomatosis: a case report and literature review.
Kapetanakis V; Karlin NJ; McCullough AE; Magtibay PM
Eur J Gynaecol Oncol; 2010; 31(6):701-2. PubMed ID: 21319522
[TBL] [Abstract] [Full Text] [Related]
12. Clinical features and treatment outcomes of 14 cases of primary ovarian non-Hodgkin's lymphoma: a single-center experience.
Zhao XY; Hong XN; Cao JN; Leaw SJ; Guo Y; Li ZT; Chang JH
Med Oncol; 2011 Dec; 28(4):1559-64. PubMed ID: 20509008
[TBL] [Abstract] [Full Text] [Related]
13. Clinical features and treatment outcomes of non-Hodgkin's lymphomas involving rare extranodal sites: a single-center experience.
Yun J; Kim SJ; Kim JA; Kong JH; Lee SH; Kim K; Ko YH; Kim WS
Acta Haematol; 2010; 123(1):48-54. PubMed ID: 19955711
[TBL] [Abstract] [Full Text] [Related]
14. Primary lymphoma of the ovary.
Elharroudi T; Ismaili N; Errihani H; Jalil A
J Cancer Res Ther; 2008; 4(4):195-6. PubMed ID: 19052394
[TBL] [Abstract] [Full Text] [Related]
15. Primary non-Hodgkin,s lymphoma of the uterine cervix.
Hanprasertpong J; Hanprasertpong T; Thammavichit T; Kongkabpan D; Tungsinmunkong K; Chandeying N
Asian Pac J Cancer Prev; 2008; 9(2):363-6. PubMed ID: 18712992
[TBL] [Abstract] [Full Text] [Related]
16. [A clinicopathologic analysis of primary ovarian non-Hodgkin's lymphoma].
Tang QL; Yang KZ; Liu WP; Peng ZL; Li JM; Li GD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):641-3, 655. PubMed ID: 16909622
[TBL] [Abstract] [Full Text] [Related]
